September 9, 2026
Nutriband CEO to Speak at Nasdaq Biotech Summit, Highlighting Abuse-Deterrent Patch Technology
September 9, 2026
Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting Progress of PTSD Candidate SPC-15
September 9, 2026
Quantum BioPharma’s Lucid-MS Gains FDA Clearance for Phase 2 Trial, Drawing Analyst Buy Rating
September 9, 2026
Helus Pharma CEO to Speak at H.C. Wainwright Conference Amid Promising Clinical Pipeline
September 9, 2026
Moody Capital Solutions Sets Date for 2026 Disruptive Growth & Life Sciences Conference
September 9, 2026
GeoVax Welcomes Global Mpox Vaccine Stockpile, Highlights GEO-MVA’s Role in Diversifying Supply
September 9, 2026
Voyageur Pharmaceuticals Hits First Milestone in Bayer Iodine Feasibility Study, Receives $1 Million
September 9, 2026
Translational Longevity Takes Center Stage: New Report and Boston Summit Aim to Bridge the Gap Between Discovery and Patient Care
September 9, 2026
Wellness Index Report Highlights Translational Longevity as Key to Delivering Longevity Science to Patients
September 9, 2026
Retail Expert Mitch Gould to Share Decades of Experience at ECRM Vitamin, Weight Management & Sports Nutrition Session
September 9, 2026
Shenzhen-Hong Kong-Guangzhou Innovation Cluster Retains Global Top Spot in WIPO Index
September 9, 2026
Tumor Microenvironment Drives Natural Killer Cell Diversity, Reshaping Cancer Immunotherapy Landscape
September 9, 2026
LiverRight and Aegle Medical Solutions Partner to Expand Access to Liver Disease Detection and Care
September 9, 2026
Creative Biolabs Expands Single-Cell Multi-Omics and RNA Sequencing Services to Advance Biomedical Research
September 8, 2026
Greenland Mines Advances Rare Earth Strategy with Q4 Biotech Spin-Off and Sarfartoq Acquisition
September 8, 2026
Nano-X Imaging Expands Nanox.ARC Distribution in New England Through New Partnership
September 8, 2026
VERAXA Biotech Appoints Raju Willener as CFO to Drive Capital Strategy and Pipeline Growth
September 8, 2026
Scinai Immunotherapeutics Streamlines Operations to Prioritize NanoAb Platform and CDMO Growth
September 8, 2026
Onco-Innovations Advances ONC010 Toward Clinical Trials with Manufacturing and Capital Milestones
September 8, 2026
Wearable Devices to Showcase Neural Sensing for Physical AI and Humanoid Robotics at Tel Aviv Event
September 8, 2026
Quantum BioPharma Gets FDA Clearance for Phase 2 Trial of First-in-Class MS Drug Candidate
September 8, 2026
Ocumetics Begins Patient Recruitment for Group Two Clinical Surgeries of Its Accommodating Intraocular Lens
September 8, 2026
Quantum BioPharma Gets FDA Green Light for First-in-Class MS Drug Targeting Myelin Repair
September 8, 2026
Quantum BioPharma Cleared to Begin Phase 2 Trial of Lucid-MS for Multiple Sclerosis
September 8, 2026
Quantum BioPharma Gains FDA Clearance for Lucid-MS Phase 2 Trial in Multiple Sclerosis
September 8, 2026
Quantum BioPharma’s Lucid-MS Gets FDA Clearance for Phase 2 Trial in Multiple Sclerosis
September 8, 2026
American Fusion Expands Patent Portfolio to 130 Applications, Evaluates Uplisting to National Exchange
September 8, 2026
LGL Group Featured at Disruptive Growth & Life Sciences Conference, Highlighting Its Dual Strategy
September 8, 2026
Tonix Pharmaceuticals Promotes Thomas Englese to Chief Commercial Officer Amid TONMYA Launch
September 7, 2026
AcroMeta to Enter Ambient Temperature Cellular Logistics Through Strategic Partnership With Macro HRD SG Pte. Ltd.
September 4, 2026
AOM Capital Provides $3.8 Million Bridge Loan to Healthcare Firm Amid Reimbursement Delays
September 4, 2026
Nanox Imaging Expands U.S. Distribution of Nanox.ARC Through New England Partnership
September 4, 2026
Onco-Innovations Advances ONC010 Toward Clinical Trials with Key Manufacturing Milestones
September 4, 2026
VERAXA Biotech Appoints Veteran Finance Executive Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth
September 4, 2026
ZC Institute Unveils Fusion Reactor Prototype Plan and Independent Neutron-Deflection Tests
September 3, 2026
OS Therapies to Present at Moody Capital Conference Amid Key Regulatory Milestones for OST-HER2
September 3, 2026
Immunotherapy Before Surgery May Improve Glioblastoma Outcomes, Preclinical Study Finds
